Giving Cardiovascular Clinicians a Voice in Evidence Generation: A Collaboration Between FDA and JACC

IF 21.7 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of the American College of Cardiology Pub Date : 2024-12-11 DOI:10.1016/j.jacc.2024.11.022

Haider J. Warraich, Harlan M. Krumholz, Robert M. Califf

引用次数: 0

Abstract

Section snippets

Funding Support and Author Disclosures

Dr Warraich has served on the medical advisory board for GoodRx. Dr Krumholz is the Editor-in-Chief of JACC; has received stock options for advisory roles from Element Science and Identifeye; has received payments for advisory roles from F-Prime; is a cofounder of and holds equity in Hugo Health, Refactor Health, and ENSIGHT-AI; and is associated with research contracts through Yale University from Janssen, Kenvue, Novartis, and Pfizer. Dr Califf has been an employee of and held equity in

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the American College of Cardiology 医学-心血管系统

CiteScore

42.70

自引率

3.30%

发文量

5097

审稿时长

2-4 weeks

期刊介绍： The Journal of the American College of Cardiology (JACC) publishes peer-reviewed articles highlighting all aspects of cardiovascular disease, including original clinical studies, experimental investigations with clear clinical relevance, state-of-the-art papers and viewpoints. Content Profile: -Original Investigations -JACC State-of-the-Art Reviews -JACC Review Topics of the Week -Guidelines & Clinical Documents -JACC Guideline Comparisons -JACC Scientific Expert Panels -Cardiovascular Medicine & Society -Editorial Comments (accompanying every Original Investigation) -Research Letters -Fellows-in-Training/Early Career Professional Pages -Editor’s Pages from the Editor-in-Chief or other invited thought leaders